Clinical Trials
2 trialsNCT05029960 2026-06-03
Tolerability and Activity of Brivaracetam (BRV) in Patients With Diffuse Gliomas
University of Rochester
Phase EARLY_PHASE1 Terminated
NCT04485104 2025-10-31
Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures
Jazz Pharmaceuticals
Phase 3 Terminated